Drawing for BIOGLUTIDE

USPTO serial 99326765

BIOGLUTIDE

Status 641Office Action
Filing date
Aug 7, 2025
Status date
Jul 10, 2026
Registration date
Examiner
KIRCHGASSER, ROSS LEONARD

Need help with BIOGLUTIDE?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: 10 Oct 2026

Office Action issues

The USPTO found no conflicting marks, which is positive. However, the current specimen has been rejected as it is considered promotional advertising rather than acceptable proof of use in commerce.

Owner

  • Biomed Industries, Inc.

    San Jose, CA, US

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disordersACTIVENov 5, 2023

Prosecution history

DateCodeEvent
Jul 10, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 10, 2026GNRTNON-FINAL ACTION E-MAILED
Jul 10, 2026CNRTNON-FINAL ACTION WRITTEN
Jun 24, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2026NREVNOTICE OF REVIVAL - E-MAILED
Jun 24, 2026PETGPETITION TO REVIVE-GRANTED
Jun 24, 2026PROATEAS PETITION TO REVIVE RECEIVED
Apr 8, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 8, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 23, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2025GNRTNON-FINAL ACTION E-MAILED
Dec 23, 2025CNRTNON-FINAL ACTION WRITTEN
Dec 22, 2025DOCKASSIGNED TO EXAMINER
Aug 7, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Aug 7, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2025NWAPNEW APPLICATION ENTERED

Related guidance